Sickle Cell Disease
Showing NaN - NaN of 41
The Living With a Long-Term Condition Study
Recruiting
- Asthma
- +44 more
- Living with LTC Questionnaire
-
London, United KingdomKing's College London
Oct 10, 2023
Sickle Cell Disease Trial in Adana, Mersin (NDec - oral decitabine-tetrahydrouridine, HU - Hydroxyurea, Placebo)
Recruiting
- Sickle Cell Disease
- NDec - oral decitabine-tetrahydrouridine
- +2 more
-
Oakland, California
- +39 more
Jan 24, 2023
Sickle Cell Disease Trial in Worldwide (VIT-2763 120 mg, VIT-2763 360 mg, VIT-2763 240 mg)
Recruiting
- Sickle Cell Disease
- VIT-2763 120 mg
- +4 more
-
Birmingham, Alabama
- +12 more
Jan 20, 2023
A Long-term Follow-up Study in Subjects Who Received CTX001
Enrolling by invitation
- Beta-Thalassemia
- +6 more
- CTX001
-
New York, New York
- +12 more
Nov 18, 2022
Sickle Cell Disease Trial in Netherlands, United Kingdom, United States (CSL889)
Recruiting
- Sickle Cell Disease
- CSL889
-
Chicago, Illinois
- +12 more
Oct 11, 2022
Sickle Cell Disease Trial in Worldwide (Etavopivat Tablets, Placebo Tablets)
Recruiting
- Sickle Cell Disease
- Etavopivat Tablets Low dose
- +3 more
-
Birmingham, Alabama
- +77 more
Oct 11, 2022
Sickle Cell Disease Trial in Lebanon, United Kingdom, United States (Voxelotor)
Enrolling by invitation
- Sickle Cell Disease
-
Washington, District of Columbia
- +10 more
Sep 27, 2022
Sickle Cell Disease Trial in France, United Kingdom, United States (Red Blood Cell, Standard of care)
Recruiting
- Sickle Cell Disease
- Red Blood Cell
- Standard of care
-
Tuscaloosa, Alabama
- +19 more
Aug 23, 2022
Cancer, COPD, Asthma Trial in London (SELF-BREATHE)
Recruiting
- Cancer
- +11 more
- SELF-BREATHE
-
London, United KingdomKing's College Hospital NHS Foundation TRUST
Sep 1, 2021
Iron Overload, Sickle Cell Disease, Other Anemias Trial in Worldwide (Deferiprone, Deferoxamine)
Terminated
- Iron Overload
- +2 more
-
Oakland, California
- +32 more
Jul 16, 2021
Sickle Cell Disease Trial in London (Aes-103, Placebo)
Terminated
- Sickle Cell Disease
- Aes-103
- Placebo
-
London, United KingdomQuintiles Ltd. - Quintiles Drug Research Unit, 6 Newcomen Street
May 3, 2021
Sickle Cell Disease Trial in Worldwide (Ticagrelor, Placebo)
Sickle Cell Disease Trial in Worldwide (voxelotor, Placebo)
Multi-Center Study of Iron Overload: Pilot Study
Completed
- Sickle Cell Disease
- +2 more
-
Oakland, California
- +2 more
Sep 22, 2020
Multi-Center Study of Iron Overload: Survey Study (MCSIO)
Completed
- Sickle Cell Disease
- +2 more
-
Oakland, California
- +7 more
Sep 22, 2020